Effect of Alemtuzumab vs. Interferon beta-1a on Brain Atrophy in Patients with Early, Active Relapsing-Remitting Multiple Sclerosis

被引：0
|
作者：
Zivadinov, Robert
Dwyer, Michael
Bergsland, Niels
Hussein, Sara
Durfee, Jackie
Ramasamy, Deepa
Cherneva, Mariya
Willis, Laura
Cox, Jennifer
Kennedy, Cheryl
Margolin, David
Rizzo, Marco
Palmer, Jeffrey
机构：
来源：
NEUROLOGY | 2011年 / 76卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A388 / A388
页数：1
相关论文
共 50 条
  • [41] The use of interferon beta in relapsing-remitting multiple sclerosis
    Etheridge, LJ
    Beverley, DW
    Ferrie, C
    McManus, E
    ARCHIVES OF DISEASE IN CHILDHOOD, 2004, 89 (08) : 789 - 791
  • [42] Safety of alemtuzumab by treatment course in patients with active relapsing-remitting multiple sclerosis
    Clanet, M.
    Hunter, S. F.
    Palmer, J.
    Oyuela, P.
    Margolin, D. H.
    JOURNAL OF NEUROLOGY, 2014, 261 : S300 - S300
  • [43] Safety of alemtuzumab by treatment course in patients with active relapsing-remitting multiple sclerosis
    Clanet, M.
    Hunter, S. F.
    Palmer, J.
    Oyuela, P.
    Margolin, D. H.
    EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 : 453 - 453
  • [44] Brain atrophy as a non-response predictor to interferon-beta in relapsing-remitting multiple sclerosis
    Ignacio Rojas, Juan
    Patrucco, Liliana
    Miguez, Jimena
    Besada, Cristina
    Cristiano, Edgardo
    NEUROLOGICAL RESEARCH, 2014, 36 (07) : 615 - 618
  • [45] Real-world propensity score comparison of treatment effectiveness of peginterferon beta-1a vs. subcutaneous interferon beta-1a, glatiramer acetate, and teriflunomide in patients with relapsing-remitting multiple sclerosis
    Reder, Anthony T.
    Arndt, Nancy
    Roman, Cortnee
    Geremakis, Caroline
    Mendoza, Jason P.
    Su, Ray
    Makin, Charles
    Avila, Robin L.
    Vignos, Megan C.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 51
  • [46] Alemtuzumab improves Expanded Disability Status Scale functional system scores better than interferon beta-1a in patients with relapsing-remitting multiple sclerosis
    Fox, Edward J.
    MULTIPLE SCLEROSIS, 2009, 15 (11): : 1396 - 1397
  • [47] Effect of intravenous methylprednisolone on brain atrophy in relapsing-remitting multiple sclerosis
    Zivadinov, R
    Rudick, RA
    De Masi, R
    Nasuelli, D
    Ukmar, M
    Pozzi-Mucelli, RS
    Grop, A
    Cazzato, G
    Zorzon, M
    NEUROLOGY, 2001, 56 (08) : A192 - A192
  • [48] Comparison of fingolimod with interferon beta-1a in relapsing-remitting multiple sclerosis: a randomised extension of the TRANSFORMS study
    Khatri, Bhupendra
    Barkhof, Frederik
    Comi, Giancarlo
    Hartung, Hans-Peter
    Kappos, Ludwig
    Montalban, Xavier
    Pelletier, Jean
    Stites, Tracy
    Wu, Stacy
    Holdbrook, Fred
    Zhang-Auberson, Lixin
    Francis, Gordon
    Cohen, Jeffrey A.
    Cohen, J.
    Barkhof, F.
    Comi, G.
    Hartung, H.P.
    Khatri, B.
    Montalban, X.
    Pelletier, J.
    Easton, D.
    Calandra, T.
    DiMarco, J.
    Hudson, L.
    Kesselring, J.
    Laupacis, A.
    Temkin, N.
    Weinshenker, B.
    Zarbin, M.
    Barkhof, F.
    Poppe, P.
    Luetic, G.
    Cristiano, E.
    Caceres, F.
    Garcea, O.
    Correale, J.
    Ballario, C.
    Piedrabuena, R.
    Pollard, J.
    Beran, R.
    Hodgkinson, S.
    Schwartz, R.
    Heard, R.
    King, J.
    Butzkueven, H.
    Maida, E.M.
    Vass, K.
    Franta-Elmer, C.
    Berger, T.
    Aichner, F.
    LANCET NEUROLOGY, 2011, 10 (06): : 520 - 529
  • [49] Mycophenolate mofetil in combination with interferon beta-1a in the treatment of relapsing-remitting multiple sclerosis: a preliminary study
    Etemadifar, Masoud
    Kazemi, Mojtaba
    Chitsaz, Ahmad
    Hekmatnia, Ali
    Tayari, Nazila
    Ghazavi, Amirhossein
    Maghzi, Amir Hadi
    JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2011, 16 (01): : 1 - 5
  • [50] Impact of discontinuing interferon beta in patients with relapsing-remitting multiple sclerosis
    Agiela, Mabroka I. M.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 (06) : NP5 - NP5
12345